We are live on ! Find out more
BIO.B icon

Bio-Rad Laboratories Class B
BIO.B

5 hedge funds and large institutions have $797K invested in Bio-Rad Laboratories Class B in 2013 Q2 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0.14% more ownership

Funds ownership: 0%0.14% (+0.14%)

Holders
5
Holders Change
+5
Holders Change %
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Dimensional Fund Advisors
1
Dimensional Fund Advisors
Texas
$738K +$785K +6,532 New
U
2
UBS
Switzerland
$26K +$28.5K +237 New
California Public Employees Retirement System
3
California Public Employees Retirement System
California
$20K +$21.7K +181 New
Barclays
4
Barclays
United Kingdom
$7K +$7.69K +64 New
Invesco
5
Invesco
Georgia
$6K +$6.37K +53 New

BIO.B Hedge Fund Activity: Q2 2013 in Review

5 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q2 2013, worth a combined $797K.

Buyers outnumbered sellers: 5 funds opened new BIO.B positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.

  • 5 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $797K of Bio-Rad Laboratories Class B stock for Q2 2013.
  • 5 funds opened new Bio-Rad Laboratories Class B positions in Q2 2013 and 0 closed out, a net change of +5 holders.

Based on aggregated 13F filings for Q2 2013.